Roche Holding | ROG - Cost Of Sales


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

Roche Holding

Roche Holding reported CHF8.95B in Cost of Sales for its fiscal semester ending in December of 2022.


Cost Of Sales Change
AbbVie ABBV:US USD 3.97B 200M
Alcon AG ALC:SW USD 1.04B 45M
Almirall SA ALM:SM EUR 90.64M 507K
Amgen AMGN:US USD 1.68B 65M
Artemis Alpha ATS:LN GBP 490K 17K
AstraZeneca AZN:LN USD 2.05B 458M
Bayer BAYN:GR EUR 5.73B 965M
Biogen BIIB:US USD 662.8M 91.9M
Bristol-Myers Squibb BMY:US USD 2.56B 45M
Eli Lilly LLY:US USD 1.63B 78.6M
Fresenius FRE:GR EUR 7.71B 145M
Fresenius Medical Care FME:GR EUR 3.56B 94.28M
Galapagos GLPG:NA EUR 3.57M 569K
Gilead Sciences GILD:US USD 1.4B 5M
GlaxoSmithKline GSK:LN GBP 1.9B 274M
Hikma Pharmaceutical HIK:LN USD 662M 72M
Lonza Group LONN:SW CHF 2B 213M
Merck MRK:GR EUR 1.97B 311M
Merck & Co MRK:US USD 3.35B 491M
Novartis NOVN:VX USD 3.83B 8M
Orion ORNBV:FH EUR 121.8M 17.5M
Pfizer PFE:US USD 5.03B 4.8B
Philips PHIA:NA EUR 2.41B 790M
Recordati REC:IM EUR 163.65M 19.72M
Regeneron Pharmaceuticals REGN:US USD 457.5M 83.1M
Roche Holding ROG:VX CHF 8.95B 613M
UCB UCB:BB EUR 829M 16M